A detailed history of Vestmark Advisory Solutions, Inc. transactions in Exact Sciences Corp stock. As of the latest transaction made, Vestmark Advisory Solutions, Inc. holds 8,405 shares of EXAS stock, worth $456,223. This represents 0.02% of its overall portfolio holdings.

Number of Shares
8,405
Holding current value
$456,223
% of portfolio
0.02%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 06, 2025

BUY
$49.33 - $71.97 $414,618 - $604,907
8,405 New
8,405 $472,000
Q1 2024

May 15, 2024

SELL
$56.27 - $73.77 $385,393 - $505,250
-6,849 Reduced 16.5%
34,670 $2.39 Million
Q4 2023

Feb 06, 2024

BUY
$59.06 - $75.72 $2.45 Million - $3.14 Million
41,519 New
41,519 $3.07 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $9.61B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Vestmark Advisory Solutions, Inc. Portfolio

Follow Vestmark Advisory Solutions, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vestmark Advisory Solutions, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Vestmark Advisory Solutions, Inc. with notifications on news.